{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:12:05Z","timestamp":1778778725292,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"publisher","award":["2022\\u20132024"],"award-info":[{"award-number":["2022\\u20132024"]}],"id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2022-139800OB-I00"],"award-info":[{"award-number":["PID2022-139800OB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["IT1587-22"],"award-info":[{"award-number":["IT1587-22"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["CUP B93D21010860004"],"award-info":[{"award-number":["CUP B93D21010860004"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010009","name":"Edge Hill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejpb.2025.114795","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:01:53Z","timestamp":1750168913000},"page":"114795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cationic Green Solid Lipid nanoparticles by the fatty acid coacervation method for gene delivery to the cornea: preliminary studies on cell and isolated tissue models"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9390-1638","authenticated-orcid":false,"given":"Annalisa","family":"Bozza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4169-514X","authenticated-orcid":false,"given":"Marina","family":"Beraza-Millor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julen","family":"Rodr\u00edguez-Castej\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Andres","family":"Soto Arratia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezio","family":"Camisassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9739-6667","authenticated-orcid":false,"given":"Elisabetta","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-2264","authenticated-orcid":false,"given":"Arianna","family":"Marengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carmen","family":"Valsania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2478-0884","authenticated-orcid":false,"given":"Ana del","family":"Pozo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Solin\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114795_b0005","unstructured":"World Health Organization, Visual impairment and blindness fact sheet, 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment."},{"key":"10.1016\/j.ejpb.2025.114795_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108361","article-title":"Novel insights into gene therapy in the cornea","volume":"202","author":"Mohan","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2025.114795_b0015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/hum.2019.026","article-title":"New frontiers of corneal gene therapy","volume":"30","author":"Iorio","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejpb.2025.114795_b0020","article-title":"Overview of gene therapy in anterior segment","volume":"60","author":"Av","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2025.114795_b0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2025.114795_b0030","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/pharmaceutics12060584","article-title":"Topical Administration of SLN-based gene therapy for the treatment of corneal inflammation by De Novo IL-10 production","volume":"12","author":"Vicente-Pascual","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114795_b0035","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/pharmaceutics13091472","article-title":"mRNA-based nanomedicinal products to address corneal inflammation by interleukin-10 supplementation","volume":"13","author":"G\u00f3mez-Aguado","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114795_b0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1566523221666210423084233","article-title":"Gene therapy in the anterior eye segment","volume":"22","author":"Amador","year":"2021","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ejpb.2025.114795_b0045","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3390\/ijms23042306","article-title":"Delayed minocycline treatment ameliorates hydrocephalus development and choroid plexus inflammation in spontaneously hypertensive rats","volume":"23","author":"Hao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114795_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-021-00265-0","article-title":"The regulatory roles of motile cilia in CSF circulation and hydrocephalus","volume":"18","author":"Kumar","year":"2021","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ejpb.2025.114795_b0055","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2025.114795_b0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/genes8020065","article-title":"Advances in non-viral dna vectors for gene therapy","volume":"8","author":"Hardee","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.ejpb.2025.114795_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40199-023-00455-1","article-title":"Lipid nanoparticles for gene therapy in ocular diseases","volume":"31","author":"Gonz\u00e1lez","year":"2023","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114795_b0070","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2015\/10443.5394","article-title":"Non viral vectors in gene therapy - an overview","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.ejpb.2025.114795_b0075","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2217\/nnm-2018-0112","article-title":"Gene delivery in the cornea: In vitro & ex vivo evaluation of solid lipid nanoparticle-based vectors","volume":"13","author":"Vicente-Pascual","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2025.114795_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/326497","article-title":"Liposomes for use in Gene delivery","volume":"2011","author":"Balazs","year":"2011","journal-title":"Journal of Drug Delivery"},{"key":"10.1016\/j.ejpb.2025.114795_b0085","doi-asserted-by":"crossref","first-page":"13530","DOI":"10.1021\/acs.jafc.0c05759","article-title":"Conjugated fatty acids in muscle food products and their potential health benefits: a review","volume":"68","author":"Wang","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejpb.2025.114795_b0090","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2016.10.016","article-title":"Applications of lipid nanoparticles in gene therapy","volume":"109","author":"del Pozo-Rodr\u00edguez","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114795_b0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/pharmaceutics14030533","article-title":"Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy\u2014an overview on recent advances","volume":"14","author":"Jacob","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114795_b0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/02652040903031279","article-title":"Solid lipid nanoparticles produced through a coacervation method","volume":"27","author":"Battaglia","year":"2010","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2025.114795_b0105","unstructured":"A. Bozza, L. Battaglia, A. Marengo, E. Camisassa, Preparation method of lipid micro and nanoparticles from natural soaps, Italian Patent 102022000021093, 2024."},{"key":"10.1016\/j.ejpb.2025.114795_b0110","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/pharmaceutics16081051","article-title":"Green solid lipid nanoparticles by fatty acid coacervation: an innovative nasal delivery tool for drugs targeting cerebrovascular and neurological diseases","volume":"16","author":"Bozza","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114795_b0115","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00592-019-01403-9","article-title":"Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies","volume":"56","author":"Muntoni","year":"2019","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejpb.2025.114795_b0120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.numecd.2020.09.020","article-title":"Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms","volume":"31","author":"Muntoni","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114795_b0125","first-page":"505-9","article-title":"Ways to improve ocular bioavailability for topical applications","volume":"23","author":"Sirbat","year":"2000","journal-title":"Journal Francais D'ophtalmologie"},{"key":"10.1016\/j.ejpb.2025.114795_b0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1081\/DDC-120002997","article-title":"Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery","volume":"28","author":"Kaur","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2025.114795_b0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","article-title":"Ocular drug delivery: a comprehensive review","volume":"24","author":"Ahmed","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2025.114795_b0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1773-2247(12)50016-X","article-title":"Solid lipid nanoparticles prepared by coacervation method as vehicles for ocular cyclosporine","volume":"22","author":"Battaglia","year":"2012","journal-title":"Journal of drug delivery science and technology"},{"key":"10.1016\/j.ejpb.2025.114795_b0145","unstructured":"Quant-iTTM PicoGreenTM dsDNA Reagent and Kit, (n.d.). https:\/\/assets.thermofisher.com\/TFS-Assets\/LSG\/manuals\/mp07581.pdf."},{"key":"10.1016\/j.ejpb.2025.114795_b0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jchromb.2007.04.005","article-title":"Separation of topological forms of plasmid DNA by anion-exchange HPLC: Shifts in elution order of linear DNA","volume":"854","author":"Smith","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ejpb.2025.114795_b0155","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2014.02.038","article-title":"A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases","volume":"465","author":"Apaolaza","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114795_b0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/15569529609048870","article-title":"A novel approach to assessing eye irritation potential using the bovine corneal opacity and permeability assay","volume":"15","author":"Casterton","year":"1996","journal-title":"J. Toxicol. Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.ejpb.2025.114795_b0165","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.tiv.2004.04.005","article-title":"Corneal permeability in a redesigned corneal holder for the bovine cornea opacity and permeability assay","volume":"18","author":"Ubels","year":"2004","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.ejpb.2025.114795_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2024.115577","article-title":"PicoGreen assay for nucleic acid quantification - applications, challenges, and solutions","volume":"692","author":"Ban","year":"2024","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejpb.2025.114795_b0175","doi-asserted-by":"crossref","unstructured":"M.M.M.V. Ooteghem, Formulation of Ophthalmic Solutions and Suspensions. Problems and Advantages, in: Edman, P. (Ed.), Biopharmaceutics of Ocular Drug Delivery, CRC Press, Boca Raton, 1993, pp. 31\u201332. https:\/\/doi.org\/10.1201\/9780429284755-2.","DOI":"10.1201\/9780429284755-2"},{"key":"10.1016\/j.ejpb.2025.114795_b0180","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2025.114795_b0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.chemphyslip.2010.01.001","article-title":"Cationic lipid-mediated nucleic acid delivery: beyond being cationic","volume":"163","author":"Rao","year":"2010","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejpb.2025.114795_b0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2006.06.024","article-title":"Cationic lipids, lipoplexes and intracellular delivery of genes","volume":"116","author":"Wasungu","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114795_b0195","doi-asserted-by":"crossref","first-page":"17056","DOI":"10.1038\/natrevmats.2017.56","article-title":"Tools for translation: non-viral materials for therapeutic mRNA delivery","volume":"2","author":"Hajj","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ejpb.2025.114795_b0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/gt.2017.5","article-title":"Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems","volume":"24","author":"Guan","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejpb.2025.114795_b0205","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2204206","article-title":"Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment","volume":"30","author":"Jiang","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114795_b0210","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/17425247.2016.1201059","article-title":"Application of lipid nanoparticles to ocular drug delivery","volume":"13","author":"Battaglia","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114795_b0215","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejpb.2011.06.005","article-title":"Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway","volume":"79","author":"Delgado","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114795_b0220","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ejpb.2025.114795_b0225","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jconrel.2013.09.027","article-title":"Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations","volume":"172","author":"Wang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114795_b0230","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1016\/j.biomaterials.2012.05.002","article-title":"Lipid nanoparticles for hepatic delivery of small interfering RNA","volume":"33","author":"Yu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2025.114795_b0235","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/RPS.RPS_25_24","article-title":"Mudhakir, Sodium oleate functionalized simvastatin liposomes: boosting endosomal escape and anticancer efficacy in triple negative breast cancer","volume":"20","author":"Sadaqa","year":"2025","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114795_b0240","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3762\/bjnano.15.131","article-title":"Mechanistic insights into endosomal escape by sodium oleate-modified liposomes","volume":"15","author":"Sadaqa","year":"2024","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.ejpb.2025.114795_b0245","first-page":"1","article-title":"Coupling phase behavior of fatty acid containing membranes to membrane bio-mechanics, Front. Cell","volume":"7","author":"Tyler","year":"2019","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ejpb.2025.114795_b0250","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-022-02294-w","article-title":"Optimization of DOTAP\/chol cationic lipid nanoparticles for mRNA, pDNA, and oligonucleotide delivery","volume":"23","author":"Sun","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2025.114795_b0255","doi-asserted-by":"crossref","DOI":"10.1039\/D2BM00168C","article-title":"In vivo delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression","author":"Algarni","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejpb.2025.114795_b0260","first-page":"484","article-title":"New gene delivery system based on oligochitosan and solid lipid nanoparticles: \u201cin vitro\u201d and \u201cin vivo\u201d evaluation","volume":"50","author":"Delgado","year":"2013","journal-title":"Eur. J. Pharm. Sci. off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114795_b0265","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1590\/S0100-879X2003000800009","article-title":"Collagens and proteoglycans of the corneal extracellular matrix","volume":"36","author":"Michelacci","year":"2003","journal-title":"Brazilian J. Med. Biol. Res. = Rev. Bras. Pesqui. Medicas e Biol."},{"key":"10.1016\/j.ejpb.2025.114795_b0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1423-0127-19-19","article-title":"Lipid raft\/caveolae signaling is required for Cryptococcus neoformans invasion into human brain microvascular endothelial cells","volume":"19","author":"Long","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejpb.2025.114795_b0275","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.biomaterials.2015.02.027","article-title":"Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells","volume":"52","author":"Yamada","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2025.114795_b0280","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/bjo.81.1.80","article-title":"Expression of adhesion molecule CD44 on human corneas","volume":"81","author":"Zhu","year":"1997","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2025.114795_b0285","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1679\/aohc.55.503","article-title":"Localization of Hyaluronic Acid, Chondroitin Sulfate, and CD44 in Rabbit Cornea","volume":"55","author":"Miyauchi","year":"1992","journal-title":"Arch. Histol. Cytol."},{"key":"10.1016\/j.ejpb.2025.114795_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087543","article-title":"Characterization of porcine ocular surface epithelial microenvironment","volume":"24","author":"Polisetti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114795_b0295","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jfo.2020.03.005","article-title":"Detection of TSG-6-like protein in human corneal epithelium. Simultaneous presence with CD44 and hyaluronic acid","volume":"43","author":"Lardner","year":"2020","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.ejpb.2025.114795_b0300","first-page":"1345","article-title":"Optimization of immunostaining on flat-mounted human corneas","volume":"21","author":"Forest","year":"2015","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejpb.2025.114795_b0305","doi-asserted-by":"crossref","first-page":"10841","DOI":"10.1039\/c3sm51849c","article-title":"Surface chemistry study of the interactions of hyaluronic acid and benzalkonium chloride with meibomian and corneal cell lipids","volume":"9","author":"Georgiev","year":"2013","journal-title":"Soft Matter"},{"key":"10.1016\/j.ejpb.2025.114795_b0310","first-page":"173","volume":"19","author":"Ahmad","year":"2015","journal-title":"J. Anal. Sci."},{"key":"10.1016\/j.ejpb.2025.114795_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-021-00763-0","article-title":"Hyaluronic acid\u2013lipid binding","volume":"15","author":"Ewurum","year":"2021","journal-title":"BMC Chem."},{"key":"10.1016\/j.ejpb.2025.114795_b0320","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2018.05.015","article-title":"Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: design, optimization, and in vitro\/ex vivo evaluation","volume":"546","author":"Alvarez-Trabado","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114795_b0325","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2015.09.033","article-title":"Solid lipid nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: in vivo approaches in Rs1h-deficient mouse model","volume":"217","author":"Apaolaza","year":"2015","journal-title":"J. Control. Release off. J. Control. Release Soc."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:27:31Z","timestamp":1778776051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125001729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":65,"alternative-id":["S0939641125001729"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114795","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cationic Green Solid Lipid nanoparticles by the fatty acid coacervation method for gene delivery to the cornea: preliminary studies on cell and isolated tissue models","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114795"}}